AllianceBernstein
MACK

AllianceBernstein’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

AllianceBernstein’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-26,280
Closed -$166K – 3205
2018
Q1 		$166K Hold
26,280
– – ﹤0.01% 2896
2017
Q4 		$212K Buy
26,280
+3,291
+14% +$30.7K ﹤0.01% 2846
2017
Q3 		$263K Sell
22,989
-4,706
-17% -$49.5K ﹤0.01% 2815
2017
Q2 		$270K Buy
27,695
+14,388
+108% +$294K ﹤0.01% 2862
2017
Q1 		$322K Sell
13,307
-10,512
-44% -$263K ﹤0.01% 2683
2016
Q4 		$765K Hold
23,819
– – ﹤0.01% 2390
2016
Q3 		$1.19M Hold
23,819
– – ﹤0.01% 2131
2016
Q2 		$1.01M Buy
23,819
+2,428
+11% +$132K ﹤0.01% 2206
2016
Q1 		$1.41M Hold
21,391
– – ﹤0.01% 1880
2015
Q4 		$1.33M Sell
21,391
-381
-2% -$26.8K ﹤0.01% 1940
2015
Q3 		$1.46M Sell
21,772
-38
-0.2% -$3.1K ﹤0.01% 1917
2015
Q2 		$2.12M Buy
21,810
+1,334
+7% +$127K ﹤0.01% 1743
2015
Q1 		$1.91M Hold
20,476
– – ﹤0.01% 1762
2014
Q4 		$1.82M Hold
20,476
– – ﹤0.01% 1817
2014
Q3 		$1.41M Hold
20,476
– – ﹤0.01% 1969
2014
Q2 		$1.17M Buy
20,476
+415
+2% +$21.1K ﹤0.01% 2153
2014
Q1 		$795K Buy
20,061
+6,330
+46% +$271K ﹤0.01% 2266
2013
Q4 		$577K Sell
13,731
-6,826
-33% -$198K ﹤0.01% 2385
2013
Q3 		$615K Buy
20,557
+901
+5% +$31.5K ﹤0.01% 2373
2013
Q2 		$1.04M Buy
+19,656
New +$862K ﹤0.01% 2053

Other funds holding MACK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein's MACK Position: Q2 2018 in Review

AllianceBernstein sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2018, closing a stake of 26,280 shares — an estimated $166K sold.

AllianceBernstein first reported a position in MACK in Q2 2013 and held it in 20 quarters. The position peaked at $2.12M in Q2 2015. 76 funds tracked by Wall St. Rank hold MACK as of Q2 2018.

  • AllianceBernstein reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • AllianceBernstein sold 26,280 Merrimack Pharmaceuticals, Inc. shares in Q2 2018, an estimated $166K.
  • AllianceBernstein first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • AllianceBernstein's Merrimack Pharmaceuticals, Inc. position peaked at $2.12M in Q2 2015.
  • 76 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2018.

Based on AllianceBernstein's 13F filing for Q2 2018, filed 13 Aug 2018.